CORC  > 上海大学
Asymmetric dimethylarginine (ADMA) as an important risk factor for the increased cardiovascular diseases and heart failure in chronic kidney disease
Liu Xiaohong[1]; Xu Xin[2]; Shang Ruru[3]; Chen Yingjie[4]
刊名Nitric oxide : biology and chemistry
2018
卷号78页码:113-120
关键词Asymmetric dimethylarginine Dimethylarginine dimethylaminohydrolase-1 Heart failure Kidney failure Nitric oxide
ISSN号1089-8611
URL标识查看原文
内容类型期刊论文
URI标识http://www.corc.org.cn/handle/1471x/2175278
专题上海大学
作者单位1.[1]VIP Department, Shanxi Provincial People's Hospital, Taiyuan, China. Electronic address: docliuxh@163.com.
2.[2]Department of Exercise Rehabilitation, Shanghai University of Sport, Shanghai, 200438, China.
3.[3]VIP Department, Shanxi Provincial People's Hospital, Taiyuan, China.
4.[4]Cardiovascular Division and Lillehei Heart Institute, University of Minnesota, Minneapolis, MN55455, USA. Electronic address: chenx106@umn.edu.
推荐引用方式
GB/T 7714
Liu Xiaohong[1],Xu Xin[2],Shang Ruru[3],et al. Asymmetric dimethylarginine (ADMA) as an important risk factor for the increased cardiovascular diseases and heart failure in chronic kidney disease[J]. Nitric oxide : biology and chemistry,2018,78:113-120.
APA Liu Xiaohong[1],Xu Xin[2],Shang Ruru[3],&Chen Yingjie[4].(2018).Asymmetric dimethylarginine (ADMA) as an important risk factor for the increased cardiovascular diseases and heart failure in chronic kidney disease.Nitric oxide : biology and chemistry,78,113-120.
MLA Liu Xiaohong[1],et al."Asymmetric dimethylarginine (ADMA) as an important risk factor for the increased cardiovascular diseases and heart failure in chronic kidney disease".Nitric oxide : biology and chemistry 78(2018):113-120.
个性服务
查看访问统计
相关权益政策
暂无数据
收藏/分享
所有评论 (0)
暂无评论
 

除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。


©版权所有 ©2017 CSpace - Powered by CSpace